🇺🇸 FDA
Pipeline program

413ABM

MVDC-2006-004

Phase 2 other completed

Quick answer

413ABM for MALARIA is a Phase 2 program (other) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
MALARIA
Phase
Phase 2
Modality
other
Status
completed

Clinical trials